Ligand · 35I
35I · (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(3,3,3-trifluoropropyl)phthalazin-2(1H)-yl ]prop-2-en-1-one
35I, (2E)-3-{5-[(2,4-diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenyl}-1-[(1S)-1-(3,3,3-trifluoropropyl)phthalazin-2(1H)-yl ]prop-2-en-1-one (C27 H27 F3 N6 O3, 540.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB…
- Component
- 35I
- Formula
- C27 H27 F3 N6 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
35I in 2 structures; the first of them:
- 4ELF · Structure-activity relationship guides enantiomeric preference among potent inhibitors of… · 35I A203 · binds MET6, VAL7, ALA8, ASN20, LEU21, PRO26, GLU28, LEU29 and 13 more
- 4ELF · Structure-activity relationship guides enantiomeric preference among potent inhibitors of… · 35I A203 · binds MET6, VAL7, ALA8, ASN20, LEU21, PRO26, GLU28, LEU29 and 13 more
Residues it binds most
LEU 16, ASN 16, ALA 16, ARG 16, VAL 16, PRO 16, THR 16, GLN 16, GLU 16, ILE 16 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.